Cargando…
Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display
Insulin-degrading enzyme (IDE) is an atypical zinc-metalloendopeptidase that hydrolyzes insulin and other intermediate-sized peptide hormones, many of which are implicated in skin health and wound healing. Pharmacological inhibitors of IDE administered internally have been shown to slow the breakdow...
Autores principales: | Suire, Caitlin N., Nainar, Sarah, Fazio, Michael, Kreutzer, Adam G., Paymozd-Yazdi, Tara, Topper, Caitlyn L., Thompson, Caroline R., Leissring, Malcolm A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814047/ https://www.ncbi.nlm.nih.gov/pubmed/29447281 http://dx.doi.org/10.1371/journal.pone.0193101 |
Ejemplares similares
-
Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021) -
Insulin-Degrading Enzyme: Paradoxes and Possibilities
por: Leissring, Malcolm A.
Publicado: (2021) -
Quantitative, High-Throughput Assays for Proteolytic Degradation of Amylin
por: Suire, Caitlin N., et al.
Publicado: (2020) -
Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening
por: Cabrol, Christelle, et al.
Publicado: (2009) -
Cathepsin D: A Candidate Link between Amyloid β-protein and Tauopathy in Alzheimer Disease
por: Suire, Caitlin N., et al.
Publicado: (2021)